Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Structure-based design, synthesis, and activity of peptide inhibitors of RGS4 GAP activity.

Jin Y, Zhong H, Omnaas JR, Neubig RR, Mosberg HI.

Methods Enzymol. 2004;389:266-77.

PMID:
15313571
2.

Structure-based design, synthesis, and pharmacologic evaluation of peptide RGS4 inhibitors.

Jin Y, Zhong H, Omnaas JR, Neubig RR, Mosberg HI.

J Pept Res. 2004 Feb;63(2):141-6.

3.

Tetrapeptide derivatives of [D-Pen(2),D-Pen(5)]-enkephalin (DPDPE) lacking an N-terminal tyrosine residue are agonists at the mu-opioid receptor.

McFadyen IJ, Sobczyk-Kojiro K, Schaefer MJ, Ho JC, Omnaas JR, Mosberg HI, Traynor JR.

J Pharmacol Exp Ther. 2000 Dec;295(3):960-6.

PMID:
11082429
4.
5.

Opioid receptor affinity and selectivity effects of second residue and carboxy terminal residue variation in a cyclic disulfide-containing opioid tetrapeptide.

Heyl DL, Omnaas JR, Sobczyk-Kojiro K, Medzihradsky F, Smith CB, Mosberg HI.

Int J Pept Protein Res. 1991 Mar;37(3):224-9.

6.

Pharmacological characterization of [D-Ala2,Leu5,Ser6]enkephalin (DALES): antinociceptive actions at the delta non-complexed-opioid receptor.

Mattia A, Vanderah T, Mosberg HI, Omnaas JR, Bowen WD, Porreca F.

Eur J Pharmacol. 1991 Jan 17;192(3):371-5.

7.

Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity.

Mosberg HI, Heyl DL, Haaseth RC, Omnaas JR, Medzihradsky F, Smith CB.

Mol Pharmacol. 1990 Dec;38(6):924-8.

PMID:
2174509
8.

Direct dependence studies in rats with agents selective for different types of opioid receptor.

Cowan A, Zhu XZ, Mosberg HI, Omnaas JR, Porreca F.

J Pharmacol Exp Ther. 1988 Sep;246(3):950-5.

PMID:
2901490
10.

Structural requirements for delta opioid receptor binding.

Mosberg HI, Omnaas JR, Goldstein A.

Mol Pharmacol. 1987 Jun;31(6):599-602.

PMID:
3037296
11.

Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.

Porreca F, Heyman JS, Mosberg HI, Omnaas JR, Vaught JL.

J Pharmacol Exp Ther. 1987 May;241(2):393-400.

PMID:
3033214
12.

Supraspinal and spinal potency of selective opioid agonists in the mouse writhing test.

Porreca F, Mosberg HI, Omnaas JR, Burks TF, Cowan A.

J Pharmacol Exp Ther. 1987 Mar;240(3):890-4.

PMID:
3031278
13.

Covalent structure of biodegradative threonine dehydratase of Escherichia coli: homology with other dehydratases.

Datta P, Goss TJ, Omnaas JR, Patil RV.

Proc Natl Acad Sci U S A. 1987 Jan;84(2):393-7.

Supplemental Content

Loading ...
Support Center